Colistin
Top View
- Treatment Options for Colistin Resistant Klebsiella Pneumoniae: Present and Future
- Colistin and Polymyxin B: a Re-Emergence
- Colistin Update on Its Mechanism of Action and Resistance, Present and Future Challenges
- Trimethoprim-Sulfamethoxazole Vs. Colistin Or Ampicillin–Sulbactam For
- Annual Report of Antibiotic and Antimycotic Consumption 2019
- A Penicillin-Binding Protein Inhibits Selection of Colistin-Resistant
- Ceporex Cephalexin Composition: Film Coated Tablets Contain Either 250, 500 Mg Or 1 G of Cephalexin
- Efficacy of Loading Dose Colistin Versus Carbapenems for Treatment Of
- Antibiotic Use in Poultry Production and Its Effects on Bacterial Resistance
- 5275-5292.Pdf
- Cefepime Combined with Amoxicillin/Clavulanic Acid: a New Choice For
- Metabolic Analyses Revealed Time-Dependent Synergistic Killing by Colistin and Aztreonam Combination Against Multidrug-Resistant Acinetobacter Baumannii
- Polymyxin Delivery Systems: Recent Advances and Challenges
- Cross Border, Highly Individualised Treatment of a Patient with Challenging Extensively Drug-Resistant Tuberculosis
- Resistant Klebsiella Pneumoniae Strains Fatma Erdem1*, Ayham Abulaila2, Zerrin Aktas2 and Oral Oncul3
- Emergence of Nosocomial Pneumonia Caused by Colistin-Resistant Escherichia Coli in Patients Admitted to Chest Intensive Care Unit
- Coly-Mycin M Parenteral IM Or IV in Normal Adult Subjects Are Shown in Figure 1
- Colistin Combinations Veterinary Medicinal Products Were Identified with Colistin Doses of Below 50,000 IU Per Kg Body Weight